Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03365752 · ClinicalTrials.gov registry record · Phase 2
Chloroprocaine Spinal for Outpatient Knee Surgery
A Phase 2 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT03365752 is a Phase 2 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 39 participants.
The verdict
NCT03365752, a Phase 2 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
Outpatient knee surgeries with duration of less than one hour pose a challenge to the use of spinal anesthesia given that traditional agents remain in effect for 2-3 hours, thus creating a mismatch between length of surgery and anesthetic resolution. The investigators hypothesize that the use of chloroprocaine can combine the benefits of a short spinal anesthetic while avoiding the side effects of a general anesthetic, thus promoting earlier discharge.
Interventions
- DRUG Mepivacaine
- DRUG Chloroprocaine
- DRUG General Anesthetics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-06-24 |
| Est. Completion | 2021-02-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03365752
The ClinicalTrials.gov registry entry for NCT03365752 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mepivacaine is the first listed.
NCT03365752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03365752 about?
NCT03365752 is a clinical study titled "Chloroprocaine Spinal for Outpatient Knee Surgery". Outpatient knee surgeries with duration of less than one hour pose a challenge to the use of spinal anesthesia given that traditional agents remain in effect for 2-3 hours, thus creating a mismatch between length of surgery and anesthetic resolution. The investigators hypothesize that the use of chl...
What is the current status of trial NCT03365752?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2018-06-24. Estimated completion is 2021-02-04.
What interventions are being tested in trial NCT03365752?
The interventions under investigation include: Mepivacaine (DRUG), Chloroprocaine (DRUG), General Anesthetics (DRUG).
Who is sponsoring clinical trial NCT03365752?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.